Research Article
Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients
Figure 2
The ferric-reducing activity of plasma (FRAP) before (FRAP1) and after (FRAP2) cladribine treatment in SP-MS patients; .